GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Contec Medical Systems Co Ltd (SZSE:300869) » Definitions » Return-on-Tangible-Asset

Contec Medical Systems Co (SZSE:300869) Return-on-Tangible-Asset : 0.56% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Contec Medical Systems Co Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Contec Medical Systems Co's annualized Net Income for the quarter that ended in Mar. 2024 was ¥17.4 Mil. Contec Medical Systems Co's average total tangible assets for the quarter that ended in Mar. 2024 was ¥3,100.7 Mil. Therefore, Contec Medical Systems Co's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was 0.56%.

The historical rank and industry rank for Contec Medical Systems Co's Return-on-Tangible-Asset or its related term are showing as below:

During the past 11 years, Contec Medical Systems Co's highest Return-on-Tangible-Asset was 44.63%. The lowest was 4.85%. And the median was 14.81%.

SZSE:300869's Return-on-Tangible-Asset is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -2.745
* Ranked among companies with meaningful Return-on-Tangible-Asset only.

Contec Medical Systems Co Return-on-Tangible-Asset Historical Data

The historical data trend for Contec Medical Systems Co's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Contec Medical Systems Co Return-on-Tangible-Asset Chart

Contec Medical Systems Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.09 44.63 14.56 6.10 4.85

Contec Medical Systems Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.62 1.42 1.39 -3.58 0.56

Competitive Comparison of Contec Medical Systems Co's Return-on-Tangible-Asset

For the Medical Devices subindustry, Contec Medical Systems Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Contec Medical Systems Co's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Contec Medical Systems Co's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Contec Medical Systems Co's Return-on-Tangible-Asset falls into.



Contec Medical Systems Co Return-on-Tangible-Asset Calculation

Contec Medical Systems Co's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=165.766/( (3675.332+3157.202)/ 2 )
=165.766/3416.267
=4.85 %

Contec Medical Systems Co's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=17.408/( (3157.202+3044.2)/ 2 )
=17.408/3100.701
=0.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data.


Contec Medical Systems Co  (SZSE:300869) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Contec Medical Systems Co Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Contec Medical Systems Co's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Contec Medical Systems Co (SZSE:300869) Business Description

Traded in Other Exchanges
N/A
Address
No. 112, Qinhuang West Street, Economic and Technological Development Zone, Hebei Province, Qinhuangdao, CHN, 066004
Contec Medical Systems Co Ltd is engaged in research and development, production and sales of medical diagnosis and monitoring equipment. The company's products portfolio includes Blood pressure series; Blood oxygen series; Multi-parameter monitoring series; In Vitro Diagnostic Series; EEG series; Breathing sleep series; ECG series; Digital Image Series; Fetal Monitoring Series; Arteriosclerosis Series; Telemedicine and health management; and Home health products.
Executives
Xu Yun Long Executives
Zheng Min Directors, Directors, and Executives
Yang Zhi Shan Directors, executives
Wang Gui Li Director
Liu Zhen Hong Executives
Kou Guo Zhi Executives
Gao Rui Bin Supervisors
Fu Chun Yuan Executives

Contec Medical Systems Co (SZSE:300869) Headlines

No Headlines